Christopher C. Goodnow

44.6k total citations · 9 hit papers
280 papers, 29.9k citations indexed

About

Christopher C. Goodnow is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Christopher C. Goodnow has authored 280 papers receiving a total of 29.9k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Immunology, 70 papers in Molecular Biology and 55 papers in Genetics. Recurrent topics in Christopher C. Goodnow's work include T-cell and B-cell Immunology (174 papers), Immune Cell Function and Interaction (154 papers) and Immunotherapy and Immune Responses (57 papers). Christopher C. Goodnow is often cited by papers focused on T-cell and B-cell Immunology (174 papers), Immune Cell Function and Interaction (154 papers) and Immunotherapy and Immune Responses (57 papers). Christopher C. Goodnow collaborates with scholars based in Australia, United States and United Kingdom. Christopher C. Goodnow's co-authors include James I. Healy, Jason G. Cyster, Ricardo E. Dolmetsch, Richard S. Lewis, Carola G. Vinuesa, Robert Brink, Antony Basten, Suzanne B. Hartley, J. Crosbie and Adrian Liston and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Christopher C. Goodnow

278 papers receiving 29.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential activation of transcription factors induced by Ca2+ response amplitude and duration

1997 1.4k citations Christopher C. Goodnow et al. profile →
Differential activation of transcription factors induced by Ca2+ response amplitude and duration

1997 1.4k citations Christopher C. Goodnow et al. profile →
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice

1988 1.3k citations Christopher C. Goodnow, Robert Brink et al. profile →
C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity

1996 941 citations Christopher C. Goodnow et al. Science profile →
A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity

2005 690 citations Christopher C. Goodnow et al. profile →
Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis

2008 585 citations Christopher C. Goodnow et al. profile →
Aire regulates negative selection of organ-specific T cells

2003 583 citations Adrian Liston, Sylvie Lesage et al. profile →
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens

1991 575 citations Robert Brink, Christopher C. Goodnow et al. profile →
Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus

2009 534 citations Christopher C. Goodnow et al. profile →

Peers

Countries citing papers authored by Christopher C. Goodnow

Since Specialization

Citations

This map shows the geographic impact of Christopher C. Goodnow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Goodnow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Goodnow more than expected).

Fields of papers citing papers by Christopher C. Goodnow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher C. Goodnow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Goodnow. The network helps show where Christopher C. Goodnow may publish in the future.

Co-authorship network of co-authors of Christopher C. Goodnow

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher C. Goodnow. A scholar is included among the top collaborators of Christopher C. Goodnow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher C. Goodnow. Christopher C. Goodnow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Convergent mutation trajectories convert functional self-tolerance in IGHV4-34 B cells to genetic tolerance encoded in the antibody 2025 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Katherine Jackson, Timothy J. Peters, Etienne Masle‐Farquhar, Deborah L. Burnett, (unknown), (unknown), (unknown), Lisa A. Miosge, Stewart A. Smith, David C. Tscharke, Robert Brink, Christopher C. Goodnow, Joanne H. Reed	0
2	Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL 2023 ·Leukemia ·(unknown), (unknown), (unknown), (unknown), Jeongmin Woo, Matthew D. Blunt, Francesco Forconi, Freda K. Stevenson, Christopher C. Goodnow, Amanda J. Russell, Peter Humburg, Graham Packham, Andrew J. Steele, Jonathan C. Strefford	2
3	SATB1 ensures appropriate transcriptional programs within naïve CD8⁺ T cells 2022 ·Immunology and Cell Biology ·Simone Nüssing, Lisa A. Miosge, (unknown), Moshe Olshansky, Adele Barugahare, Carla M. Roots, Yovina Sontani, E. Bridie Day, Marios Koutsakos, Katherine Kedzierska, Christopher C. Goodnow, Brendan E. Russ, Stephen R. Daley, Stephen T. Turner	2
4	Uncontrolled CD21low age-associated and B1 B cell accumulation caused by failure of an EGR2/3 tolerance checkpoint 2022 ·Cell Reports ·Etienne Masle‐Farquhar, Timothy J. Peters, Lisa A. Miosge, Ian A. Parish, Christoph Weigel, Christopher C. Oakes, Joanne H. Reed, Christopher C. Goodnow	15
5	DOCK8 deficiency diminishes thymic T‐regulatory cell development but not thymic deletion 2021 ·Clinical & Translational Immunology ·Katrina L. Randall, (unknown), Andrew Ziolkowski, (unknown), Christopher C. Goodnow, Stephen R. Daley	4
6	IRF2 transcriptionally induces GSDMD expression for pyroptosis 2019 ·Science Signaling ·Nobuhiko Kayagaki, Bettina L. Lee, Irma B. Stowe, Opher S. Kornfeld, Karen O’Rourke, Kathleen M. Mirrashidi, Benjamin Haley, Colin Watanabe, Merone Roose‐Girma, Zora Modrušan, Sarah Kummerfeld, Rohit Reja, Yafei Zhang, Vicky Cho, T. Daniel Andrews, Lucy X. Morris, Christopher C. Goodnow, Edward M. Bertram, Vishva M. Dixit	131
7	αβ T‐cell receptors with a central CDR 3 cysteine are enriched in CD 8αα intraepithelial lymphocytes and their thymic precursors 2018 ·Immunology and Cell Biology ·(unknown), Mandeep Singh, Stuart K. Archer, Anna Chan, Paul F. Harrison, Christopher C. Goodnow, Stephen R. Daley	21
8	Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination 2018 ·Science ·Deborah L. Burnett, David B. Langley, Peter Schofield, Jana R. Hermes, Tyani D. Chan, Jennifer Jackson, Katherine Bourne, Joanne H. Reed, Kate Patterson, Benjamin T. Porebski, Robert Brink, Daniel Christ, Christopher C. Goodnow	91
9	B-cell receptor reconstruction from single-cell RNA-seq with VDJPuzzle 2018 ·Bioinformatics ·Simone Rizzetto, David Koppstein, Jerome Samir, Mandeep Singh, Joanne H. Reed, Curtis Cai, Andrew R. Lloyd, Auda A. Eltahla, Christopher C. Goodnow, Fabio Luciani	66
10	Understanding Immune Tolerance of Cancer: Re‐Purposing Insights from Fetal Allografts and Microbes 2018 ·BioEssays ·(unknown), Prunella Blinman, Wendy A. Cooper, Michael Boyer, Steven Kao, Christopher C. Goodnow	7
11	Synergistic cooperation and crosstalk between MYD88L265P and mutations that dysregulate CD79B and surface IgM 2017 ·The Journal of Experimental Medicine ·James Q. Wang, Yogesh Jeelall, Peter Humburg, (unknown), (unknown), Hee Min Yoo, Christopher C. Goodnow, Keisuke Horikawa	24
12	Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in the hepatic sinusoids 2017 ·Science Immunology ·Hayley A. McNamara, Yu Cai, (unknown), Yovina Sontani, Carla M. Roots, Lisa A. Miosge, (unknown), Henry J. Sutton, Vitaly V. Ganusov, William R. Heath, Patrick Bertolino, Christopher C. Goodnow, Ian A. Parish, Anselm Enders, Ian A. Cockburn	128
13	IgD attenuates the IgM-induced anergy response in transitional and mature B cells 2016 ·Nature Communications ·Zahra Sabouri, (unknown), (unknown), Peter Humburg, Mehmet Yabas, H Bergmann, Keisuke Horikawa, Carla M. Roots, (unknown), Clara Young, T. Daniel Andrews, Matthew A. Field, Anselm Enders, Joanne H. Reed, Christopher C. Goodnow	66
14	Inhibiting TLR9 and other UNC93B1-dependent TLRs paradoxically increases accumulation of MYD88L265P plasmablasts in vivo 2016 ·Blood ·James Q. Wang, Bruce Beutler, Christopher C. Goodnow, Keisuke Horikawa	9
15	Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity 2014 ·Proceedings of the National Academy of Sciences ·Zahra Sabouri, Peter R. Schofield, Keisuke Horikawa, (unknown), David Kipling, Katrina L. Randall, David B. Langley, Brendan Roome, Rodrigo Vazquez-Lombardi, Romain Rouet, Jana R. Hermes, Tyani D. Chan, Robert Brink, Deborah K. Dunn‐Walters, Daniel Christ, Christopher C. Goodnow	181
16	Helios marks strongly autoreactive CD4+ T cells in two major waves of thymic deletion distinguished by induction of PD-1 or NF-κB 2013 ·The Journal of Experimental Medicine ·Stephen R. Daley, (unknown), Christopher C. Goodnow	127
17	T-cell regulation by casitas B-lineage lymphoma ( Cblb ) is a critical failsafe against autoimmune disease due to autoimmune regulator ( Aire ) deficiency 2010 ·Proceedings of the National Academy of Sciences ·Charis E. Teh, Stephen R. Daley, Anselm Enders, Christopher C. Goodnow	38
18	Essential role of membrane cholesterol in accelerated BCR internalization and uncoupling from NF-κB in B cell clonal anergy 2006 ·The Journal of Experimental Medicine ·Mathieu Bléry, Lina E. Tze, Lisa A. Miosge, Jesse E. Jun, Christopher C. Goodnow	46
19	Gene Dosage–limiting Role of Aire in Thymic Expression, Clonal Deletion, and Organ-specific Autoimmunity 2004 ·The Journal of Experimental Medicine ·Adrian Liston, Daniel H.D. Gray, Sylvie Lesage, Anne Fletcher, Judith Wilson, Kylie E. Webster, Hamish S. Scott, Richard L. Boyd, Leena Peltonen, Christopher C. Goodnow	241
20	Signals regulating B lymphocyte migration and survival in lymphoid tissues 1996 ·The FASEB Journal ·Jason G. Cyster, Matthew C. Thomas, Christopher C. Goodnow	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact